Literature DB >> 10703904

Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double-blind clinical trial.

A Balzarini1, E Felisi, A Martini, F De Conno.   

Abstract

The aim of this study was to assess the effects of Belladonna 7cH and X-ray 15cH associated in the treatment of acute radiodermatitis. A randomized double-blind placebo-controlled clinical trial involving 66 patients who had been operated on for breast cancer and were undergoing radiotherapy was conducted. The following parameters were assessed over ten weeks: breast skin colour, warmth, swelling and pigmentation. The efficacy of the treatment was assessed by the comparison of these parameters taken individually and by calculating an Index of Total Severity (sum of the scores of the four parameters) during radiotherapy, and during recovery, 15 and 30 d after the end of the radiotherapy. The differences of the scores of the Index of Total Severity during Radiotherapy were not statistically significant, but showed a trend towards a better activity of the homoeopathic medicine compared to placebo. Analysis of the data on Total Severity during recovery, showed a statistically significant benefit of the active medicines over placebo. The homeopathic medicines had particular effectiveness on the heat of the skin. The limited number of patients observed and the posology employed could have interfered with the significance of the results. Chemotherapy and hormonotherapy do not seem to affect the results.

Entities:  

Mesh:

Year:  2000        PMID: 10703904     DOI: 10.1054/homp.1999.0328

Source DB:  PubMed          Journal:  Br Homeopath J        ISSN: 0007-0785


  8 in total

Review 1.  The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline.

Authors:  Amanda Bolderston; Nancy S Lloyd; Rebecca K S Wong; Lori Holden; Linda Robb-Blenderman
Journal:  Support Care Cancer       Date:  2006-06-07       Impact factor: 3.603

2.  Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature.

Authors:  N Salvo; E Barnes; J van Draanen; E Stacey; G Mitera; D Breen; A Giotis; G Czarnota; J Pang; C De Angelis
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

Review 3.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

4.  A homeopathic remedy from arnica, marigold, St. John's wort and comfrey accelerates in vitro wound scratch closure of NIH 3T3 fibroblasts.

Authors:  Katarina Hostanska; Matthias Rostock; Joerg Melzer; Stephan Baumgartner; Reinhard Saller
Journal:  BMC Complement Altern Med       Date:  2012-07-18       Impact factor: 3.659

5.  Rat models of acute inflammation: a randomized controlled study on the effects of homeopathic remedies.

Authors:  Anita Conforti; Paolo Bellavite; Simone Bertani; Flavia Chiarotti; Francesca Menniti-Ippolito; Roberto Raschetti
Journal:  BMC Complement Altern Med       Date:  2007-01-17       Impact factor: 3.659

Review 6.  Add-On Complementary Medicine in Cancer Care: Evidence in Literature and Experiences of Integration.

Authors:  Elio Rossi; Mariella Di Stefano; Fabio Firenzuoli; Maria Valeria Monechi; Sonia Baccetti
Journal:  Medicines (Basel)       Date:  2017-01-24

7.  Feasibility of Homeopathic Treatment for Symptom Reduction in an Integrative Oncology Service.

Authors:  Noah Samuels; Yakov Freed; Rony Weitzen; Merav Ben-David; Yair Maimon; Uri Eliyahu; Raanan Berger
Journal:  Integr Cancer Ther       Date:  2017-11-02       Impact factor: 3.279

8.  Homeopathy for cancer?

Authors:  E Ernst
Journal:  Curr Oncol       Date:  2007-08       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.